Welcome to our dedicated page for Inspira Technologies Oxy Bhn SEC filings (Ticker: IINN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Inspira Technologies Oxy B.H.N. Ltd. filings document foreign-private-issuer current reports, shareholder meeting materials and registration statement incorporation for its technology business. Form 6-K reports furnish press releases on AME system orders, commercial deployments, the QTREX platform, cryogenic interconnect development and shareholder communications, while proxy materials cover voting matters such as amendments to the company's articles of association.
Other filings describe governance and officer appointments, ordinary-share voting procedures, Form F-3 and Form S-8 registration statement references, and capital-structure context tied to the company's Nasdaq-listed securities and medical technology operations.
QTREX Quantum Ltd. Chief Technology Officer Daniella Yechezkely Hayon reported an open-market sale of 50,000 Ordinary Shares at $3.00 per share. The sale followed the vesting of Restricted Share Units, where each RSU converted into one Ordinary Share. After this transaction, she directly holds 780,000 Ordinary Shares.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales totaling 30,000 Ordinary Shares that were received upon vesting of Restricted Share Units. The underlying shares were then sold under an existing Rule 10b5-1 trading plan, indicating the transactions were pre-scheduled.
The reported sales included 28,100 shares at $3.50 per share on May 31, 2026 and 1,900 shares at $3.51 per share on May 29, 2026. After these transactions, Yafit directly holds 870,000 Ordinary Shares, so the disposals represent a small portion of her overall position.
QTREX Quantum Ltd. COO and VP of R&D Shabtay Abraham exercised employee stock options to acquire 95,239 Ordinary Shares on May 29, 2026. These exercises were reported as derivative transactions and did not involve any open‑market buying or selling.
Following the exercises, Abraham directly holds 1,332,713 Ordinary Shares. The options exercised came from grants made in 2020 that had fully vested by mid‑2022, with exercise prices disclosed in the footnotes in AUD and NIS terms.
QTREX Quantum Ltd. reported receiving a purchase order from a U.S.-based Fortune 500 multinational company for an Additively Manufactured Electronics (AME) system and related materials. The system will be delivered to one of the customer’s sites outside the United States and is designed to enable intricate electronic structures in a single workflow.
The company states that this order expands its commercial AME footprint with a global enterprise customer and reinforces its position as an advanced AME platform for demanding technology environments. QTREX expects the order to contribute to upcoming financial results and to support its growing AME commercial activity.
QTREX focuses on AME-based quantum connectivity solutions and mission-critical defense, aerospace, missile, space and other applications, while also working to monetize parts of its medical technology portfolio.
QTREX Quantum Ltd. has raised $10 million in a private placement with a single institutional investor. The company is issuing 3,895,000 ordinary shares at $1.50 per share and pre-funded warrants for 2,771,667 shares at $1.4999 each, exercisable at $0.0001 per share. The deal closed on June 1, 2026 and the company plans to use the net proceeds for working capital and general corporate purposes.
The investor’s stake is capped by a 9.99% beneficial ownership limitation, with pre-funded warrants used to avoid exceeding that level. QTREX agreed not to issue additional ordinary shares or equivalents for 30 days after closing, subject to exceptions. A.G.P./Alliance Global Partners acted as exclusive placement agent, earning a 7.0% cash fee plus up to $50,000 in reimbursed expenses and $12,500 in non-accountable expenses.
Under a Registration Rights Agreement, QTREX must file a resale registration statement on Form F-3 (or another available form) within 5 trading days to cover the ordinary shares and shares underlying the pre-funded warrants, and use commercially reasonable efforts to have it declared effective within specified timeframes.
The filing reports sales of ordinary shares by a holder identified as Yafit Tehila under Form 144. The excerpt lists three sell transactions: 30,000 shares on 05/27/2026 for $60,561.18, 30,000 shares on 05/28/2026 for $83,400.00, and 1,900 shares on 05/29/2026 for $6,675.46. The filing also records 160,000 shares issued upon vesting of RSUs to Quantum Ltd. on 02/05/2024. Other data in the excerpt (including a Nasdaq line and numeric fields) appear as issuer/security metadata.
Quantum Ltd. submitted a notice regarding 50,000 Ordinary Shares associated with brokerage Oppenheimer & Co. Inc. The filing lists an aggregate value of $150,000.00, a numeric identifier 35949247, an execution/record date of 05/29/2026, and Nasdaq as the market. The excerpt also shows 50,000 shares issued on 02/05/2024 upon vesting of RSUs to the holder named Quantum Ltd.
IINN submitted a Form 144 notice reporting proposed sales of Ordinary Shares linked to recent option exercises. The filing lists 57,144 shares and 38,095 shares to be sold, each noted as "Shares acquired upon exercise of employee stock options," with the transactions dated 05/29/2026.
The filing names Oppenheimer & Co. Inc. as the broker and states "cash payment upon exercise of stock options" as the acquisition method. The Form 144 is a regulatory notice of intended resale under the Securities Act.
IINN reported proposed sales under a Form 144 for Ordinary Shares by Yafit Tehila Hatidhar. The filing lists two proposed dispositions of 30,000 shares on 05/27/2026 for $60,561.18 and 30,000 shares on 05/28/2026 for $83,400.00.
The record also shows prior issuances upon RSU vesting of 86,395 shares on 11/02/2021 and 160,000 shares on 02/05/2024, and a listed outstanding figure of 35,949,247 shares as of 05/29/2026.
QTREX Quantum Ltd. Chief Financial Officer Tehila Yafit reported open-market sales of a total of 60,000 Ordinary Shares of QTEX at prices between $2.0134 and $3.00 per share. Following these transactions, she directly holds 900,000 Ordinary Shares.
On the same dates, she exercised employee share options covering 13,605 Ordinary Shares at a conversion price of $0.12 per share, with no derivative options remaining after the exercise. The sales were executed pursuant to an existing Rule 10b5-1 trading plan, indicating they were pre-arranged rather than timed discretionarily.